Moors & Cabot Inc. Sells 2,300 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Moors & Cabot Inc. trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 33.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,637 shares of the exchange traded fund’s stock after selling 2,300 shares during the period. Moors & Cabot Inc.’s holdings in SPDR S&P Biotech ETF were worth $458,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. boosted its stake in shares of SPDR S&P Biotech ETF by 1.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock valued at $106,158,000 after purchasing an additional 18,202 shares in the last quarter. Jane Street Group LLC boosted its position in SPDR S&P Biotech ETF by 68.7% during the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock valued at $91,197,000 after acquiring an additional 391,333 shares in the last quarter. Mirae Asset Securities USA Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 50.0% in the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after acquiring an additional 300,000 shares during the period. Employees Retirement System of Texas raised its position in shares of SPDR S&P Biotech ETF by 40.8% in the 2nd quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock worth $55,984,000 after acquiring an additional 174,857 shares in the last quarter. Finally, Main Management Fund Advisors LLC lifted its stake in shares of SPDR S&P Biotech ETF by 8.3% during the 2nd quarter. Main Management Fund Advisors LLC now owns 598,200 shares of the exchange traded fund’s stock worth $55,459,000 after purchasing an additional 45,700 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

XBI opened at $96.24 on Friday. The firm has a market capitalization of $7.34 billion, a PE ratio of 11.47 and a beta of 1.11. The business’s 50-day moving average is $98.44 and its two-hundred day moving average is $96.23. SPDR S&P Biotech ETF has a 1 year low of $71.99 and a 1 year high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.